Nirmal Keshava is the Vice President of Data Science and Innovation at Cerevel Therapeutics, where he leads efforts introducing novel data-centric approaches and technologies into all parts of the drug discovery and development continuum. Previously he was the Head of Artificial Intelligence at BioXcel Therapeutics and a Senior Principal Informatics Scientist at AstraZeneca. Preceding his career in the pharmaceutical industry, he spent 15 years leading government and industry-sponsored research at MIT Lincoln Laboratory and the Charles Stark Draper Laboratory. Before that he worked as a telecommunications system engineer at Bell Communications Research. He received his B.S. and Ph.D. in electrical engineering, respectively, from UCLA and Carnegie Mellon University. He has been recognized by IEEE, NSF, and NAE.